In human hepatocellular carcinoma (HCC) tissues, the overexpression of SIRT3 increases the p53 protein level through the downregulation of MDM2 that reduces MDM2-dependent p53 degradation, indicating that SIRT3 acts as a tumor suppressor [51]. Here, SIRT3 is linked to hepatocellular carcinoma.